Charles River Laboratories International, Inc.CRLNYSE
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 2,924 | 3,540↑21.1% | 3,976↑12.3% | 4,129↑3.9% | 4,050↓1.9% |
| Cost Of Revenue | 1,850 | 2,206↑19.2% | 2,513↑14.0% | 2,627↑4.5% | 2,718↑3.5% |
| Gross Profit | 1,074 | 1,335↑24.3% | 1,463↑9.6% | 1,503↑2.7% | 1,332↓11.4% |
| Operating Expenses | 641 | 745↑16.2% | 812↑9.0% | 885↑9.1% | 1,104↑24.8% |
| Operating Income | 433 | 590↑36.3% | 651↑10.4% | 617↓5.2% | 227↓63.2% |
| Interest Expense | 86 | 74↓14.5% | 59↓19.8% | 137↑130.6% | 126↓7.6% |
| Income Before Tax | 447 | 481↑7.5% | 623↑29.6% | 581↓6.7% | 93↓84.0% |
| Income Tax Expense | 82 | 82↑0.1% | 130↑59.2% | 101↓22.6% | 68↓32.8% |
| Net Income | 364 | 391↑7.3% | 486↑24.4% | 475↓2.4% | 10↓97.8% |
| EBITDA | 768 | 820↑6.7% | 986↑20.2% | 1,032↑4.7% | 581↓43.7% |
| EPS | 7.35 | 7.77↑5.7% | 9.57↑23.2% | 9.27↓3.1% | 0.20↓97.8% |
| EPS Diluted | 7.20 | 7.60↑5.6% | 9.48↑24.7% | 9.22↓2.7% | 0.20↓97.8% |